ASICS America has signed world 100-meter sprint champion Fred Kerley has signed a deal believed to be a multi-year contract.
The athletic footwear and apparel company took to its social media pages to share the news, saying: “We are beyond excited to welcome Track & Field superstar @fkerley99 to the ASICS family.
Kerley won the gold medal in the 100 meters at the 2022 World Athletics Championships in Oregon and a silver medal at the Tokyo Olympic Games. He also won several medals at the World Championships in the 400 m and 4 × 400 m relay, including a bronze and a relay gold in 2019 and is a two-time Diamond League Champion.
The 27-year-old American sprinter is will defend his 100-meter title at the upcoming 2023 World Athletics Championships in Budapest, Hungary.
Kerley will join American middle-distance runner Donavan Brazier and Japanese tennis star Naomi Osaka other and other high-profile athletes in endorsing ASICS products.


Dollar Surges to Nine-Month High as Middle East Tensions Drive Safe-Haven Demand
Gold Prices Rebound in Asia Amid Iran War Ceasefire Hopes
U.S. Plans $115 Million Counter-Drone Investment to Secure FIFA World Cup and Major National Events
Goldman Sachs Sees Value in European Real Estate Stocks Despite Sharp Selloff
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Trump Signs Executive Order Targeting Big-Money College Athlete Payouts
How did sport become so popular? The ancient history of a modern obsession
LA28 Confirms Olympic Athletes Exempt from Trump’s Travel Ban
Trump’s U.S. Open Visit Delays Final, Fans Face Long Security Lines
China Manufacturing PMI Hits 12-Month High Amid Energy Price Concerns
Why Manchester City offered Erling Haaland the longest contract in Premier League history
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Trump's Transgender Sports Ban Faces Enforcement Challenges 



